Introduction
Apoptosis is a process of programmed cell death that is vital to normal development and the maintenance of tissue homeostasis; however, aberrations in apoptosis can lead to cancer and neurodegenerative disease (Hanahan and Weinberg, 2000; Friedlander, 2003) . Apoptosis can be triggered by both extracellular and intracellular stimuli, and is primarily executed by a family of cysteine proteases known as caspases (Thornberry and Lazebnik, 1998; Earnshaw et al., 1999; Riedl and Shi, 2004) . The extrinsic death pathway begins outside of the cell through members of the tumor necrosis factor (TNF) ligand superfamily binding to their cognate receptors (Wiley et al., 1995) .
TRAIL (tumor TNF-related apoptosis-inducing ligand), a member of the TNF ligand superfamily, can induce apoptosis in a variety of tumor cells through its receptors, death receptor 4 (DR4) and DR5 (Ashkenazi and Dixit, 1998; Johnstone et al., 2008) . Binding of TRAIL and trimerization of DRs on the cell membrane initiates apoptosis through the assembly of deathinducing signaling complex (DISC; Boldin et al., 1996; Scaffidi et al., 1999) . After binding to TRAIL, the DRs recruit the adapter protein Fas-associated protein death domain (FADD) through their cytoplasmic death domains (Medema et al., 1997) . FADD interacts with pro-caspase-8 through its death effector domain (DED) to form DISC (Ashkenazi and Dixit, 1998) . DISC mediates the self-processing of pro-caspase-8 into the active p43/p41 and p18 forms (Chang et al., 2003) . Cytoplasmic, active caspase-8 then cleaves substrates, such as caspase-3 and BH3 interacting domain death agonist (BID), and activates downstream signaling cascades transmitted through mitochondria-independent or -dependent pathways to induce apoptosis (Li et al., 1998; Stennicke et al., 1998) .
DJ-1, a conserved protein with 189 amino acids, is ubiquitously expressed but is found at particularly high levels in the testis, brain and kidney (Olzmann et al., 2004) . DJ-1 was originally identified as a novel oncogene product in conjunction with the small G-protein Ras in NIH3T3 cells (Nagakubo et al., 1997) .
DJ-1 has been reported to exhibit both cytoplasmic and nuclear distribution (Nagakubo et al., 1997; Bonifati et al., 2003) . It functions in multiple pathways that affect cell survival. DJ-1 itself can scavenge reactive oxygen species through a cysteine residue at C106, shifting its pI from 6.2 to 5.8 (Canet-Aviles et al., 2004; Andres-Mateos et al., 2007) . DJ-1 also modifies the transcription of antioxidant enzymes by stabilizing the primary regulator of antioxidant responses, nuclear factor erythroid 2-related factor (Clements et al., 2006) . DJ-1 suppresses the c-Jun N-terminal kinase (JNK) signaling pathway through its interaction with mitogen-activated protein kinase kinase kinase 1 to repress cell death (Mo et al., 2008) . In addition, it interacts with Daxx and sequesters it within the nucleus, preventing its translocation to the cytoplasm and the initiation of apoptotic signaling (Junn et al., 2005) . The anti-apoptotic function of DJ-1 is also partly attributable to its ability to regulate transcription. DJ-1 also functions as a transrepressor of a key tumor suppressor, PTEN (phosphatase and tensin homolog on chromosome 10), to regulate c-Myc and the catalytic unit of the telomerase complex, human telomerase reverse transcriptase (Sitaram et al., 2009) . It contributes to cell survival by interacting with p54nrb to inhibit the silencing activity of pyrimidine tract-binding protein-associated splicing factor (Xu et al., 2005) or by regulating androgen receptor transcriptional activity (Takahashi et al., 2001; Niki et al., 2003; Tillman et al., 2007) . Recently, DJ-1 was found to repress p53 (Bretaud et al., 2007; Fan et al., 2008a, b; Giaime et al., 2010) .
In contrast to its functions in cell survival, deletions or loss of function point mutations in DJ-1 are reported to be responsible for recessive early-onset Parkinson's disease (PD; Bonifati et al., 2003) . The most commonly studied PD-associated mutant, L166P, is reported to be unstable and to mislocalize to the mitochondria, leading to a loss of the cytoplasmic function of DJ-1 .
DJ-1 is involved in the pathogenesis of several types of cancer, such as ovarian carcinoma, melanoma and breast, lung and prostate cancer (Le Naour et al., 2001; MacKeigan et al., 2003; Hod, 2004; Pardo et al., 2006; Davidson et al., 2008) . Increased DJ-1 expression in primary lung cancer is correlated with a poor prognosis , whereas decreased DJ-1 expression enhances cell death induced by apoptotic-inducing agents (Hod, 2004) . It was reported that DJ-1 protects cells from TRAIL-induced apoptosis (Hod, 2004) . Knockdown of DJ-1 sensitizes PC-3 cells, a prostatic cancer cell line, to TRAIL-induced apoptosis, whereas overexpression of DJ-1 protects BPH-1 cells, a prostatic benign hyperplasia cell line, from TRAIL-induced apoptosis (Hod, 2004) . In cancer cell lines, the cells exhibiting higher expression levels of DJ-1 are more resistant to TRAIL-induced apoptosis (Hod, 2004; Zhang et al., 2008) . However, the mechanism by which DJ-1 protects cells from TRAIL-induced cell death is still unknown.
In this study, we demonstrate that DJ-1 competes with pro-caspase-8 to bind to FADD. This leads to the inhibition of pro-caspase-8 recruitment to FADD and protects cells from TRAIL-induced apoptosis.
Results
DJ-1 attenuates pro-caspase-8 activation and TRAIL-induced apoptosis independent of p53 Following TRAIL treatment, caspase-8 is activated and subsequently activates downstream effector caspases, such as caspase-3. This leads to the cleavage of caspase substrates, such as PARP (poly ADP-ribose polymerase; Nicholson et al., 1995; Oliver et al., 1998; Stennicke et al., 1998) . To explore the role of DJ-1 in the TRAIL-induced apoptosis pathway, we performed DJ-1 knockdown experiments. Because DJ-1 is involved in regulating p53 activity (Bretaud et al., 2007; Fan et al., 2008a, b; Giaime et al., 2010) , we performed experiments using both p53 þ / þ and p53À/À human colon cancer cells (HCT116) to determine whether p53 is involved in the DJ-1-regulated TRAIL pathway. Smallinterfering RNA against DJ-1 (siDJ-1) caused a reduction of approximately 70% of endogenous DJ-1 compared with transfections using a negative control small-interfering RNA (siNC; Figure 1a ). In HCT116 p53 þ / þ cells transfected with siNC, TRAIL treatment caused a moderate cleavage of PARP and the activation of pro-caspase-8; however, in DJ-1 knockdown cells, increased PARP cleavage and the activation of procaspase-8 were observed (Figure 1b) . Similar results were obtained using HCT116 p53À/À cells (Figure 1c) . The viability of DJ-1 knockdown HCT116 p53À/À cells was decreased compared with control knockdown cells under various doses of TRAIL treatment, although knockdown of DJ-1 alone did not decrease cell viability (Figure 1d ). These results suggest that DJ-1 attenuates the pro-caspase-8 activation and apoptosis induced by TRAIL in a p53-independent manner.
DJ-1 does not function downstream of caspase-8 activation
To identify whether DJ-1 functions upstream or downstream of active caspase-8 to protect cells from apoptosis, we used an inducible caspase-8 dimerization system to produce active caspase-8. A conditionally active form of caspase-8 (Fv-caspase-8) depends on the interactions between Fv (modified FK506 binding protein) and its divalent ligand AP20187 (AP; Chang et al., 2003; Nieminen et al., 2007) . On AP treatment, Fv-caspase-8 dimerizes and is self-activated, independent of its recruitment to DISC via FADD. We observed that Fv-caspase-8, but not its catalytically inactive form, Fv-mut-caspase-8, was self-activated, and PARP was cleaved in Fv-caspase-8-transfected H1299 cells on treatment with 100 nM AP (Figure 2a ). Microscopic cellular morphological changes ( Figure 2b ) and an increase in the number of apoptotic cells based on flow cytometry analysis using annexin V/propidium iodide staining ( Figure 2c ) were also observed in cells transfected with Fv-caspase-8 and treated with AP. To assess whether DJ-1 could protect cells from cell death after caspase-8 activation, we transfected Fv-caspase-8 into DJ-1 knockdown H1299 cells. Without AP treatment, no cleavage of PARP was observed (Figure 2d , lanes 1 and 2). In AP-treated cells, PARP cleavage was observed, and there were no differences detected between the DJ-1 knockdown and the control knockdown cells (Figure 2d , lanes 5 and 6). To determine whether DJ-1 or its PD-associated mutant L166P could protect cells after caspase-8 activation, we constructed siDJ-1-resistant mutants of wild-type DJ-1 (DJ-1(s)) and L166P (L166P(s)) and transfected them into DJ-1 knockdown cells to rescue DJ-1 levels. Overexpression of DJ-1(s) or L166P(s) in DJ-1 knockdown cells did not influence the levels of cleaved PARP in cells transfected with Fv-caspase-8 and treated with AP ( Figure 2d , lanes 7 and 8). Moreover, no differences in morphological changes (Figure 2e ) or apoptotic cell numbers ( Figure 2f) were observed, although DJ-1 levels were rescued by the overexpression of DJ-1(s) or L166P(s). These data suggest that DJ-1 cannot protect cells from death after caspase-8 activation and that DJ-1 may function upstream of active caspase-8.
DJ-1 has no effect on the mRNA and protein levels of TRAIL receptors TRAIL induces apoptosis through interaction with its receptors (Ashkenazi and Dixit, 1998) . The levels of TRAIL receptors, including death receptors and decoy receptors, are closely related to apoptosis induced by TRAIL. Because DJ-1 can function in the nucleus to regulate transcription (Clements et al., 2006; Bretaud et al., 2007; Fan et al., 2008a; Foti et al., 2010) , it is possible that DJ-1 regulates the TRAIL signaling pathway by influencing the expression of TRAIL receptors at the transcriptional level. We transfected H1299 cells with siNC or siDJ-1 and examined the mRNA levels of the four TRAIL receptors using reverse transcriptase-PCR. Although DJ-1 mRNA levels were greatly decreased following transfection of siDJ-1, no changes in the mRNA levels of the death receptors (DR4 and DR5) or decoy receptors DcR1 (decoy receptor 1) and DcR2 were observed (Figure 3a) . Moreover, overexpression of DJ-1 did not affect the mRNA levels of the TRAIL receptors (Figure 3b ). Consistent with our reverse transcriptase-PCR results, knockdown (Figure 3c ) or overexpression (Figure 3d ) of DJ-1 in H1299 cells had no effect on the protein levels of the four TRAIL receptors. Thus, our data suggest that DJ-1 does not regulate DISC by modulating the levels of TRAIL receptor expression.
DJ-1, but not L166P, interacts with FADD and inhibits TRAIL-induced apoptosis Because DJ-1 inhibits TRAIL-induced cell death but has no effects on TRAIL receptor levels and does not confer DJ-1 regulates TRAIL-induced apoptosis K Fu et al protection after caspase-8 activation, we considered the hypothesis that DJ-1 acts on the adapter protein FADD to affect the TRAIL signaling pathway. First, we performed in vitro pull-down assays to determine whether DJ-1 interacts with FADD. As shown in Figure 4A , glutathione S-transferase (GST)-DJ-1 and GST-L166P, but not GST alone, interacted with Flag-FADD expressed by Escherichia coli. To further verify the interactions between DJ-1 and FADD, we performed co-immunoprecipitation experiments using human embryonic kidney 293 (HEK 293) cells ( Figure 4B ) and H1299 cells ( Figure 4C ). Transfection of cells with equal amounts of plasmids containing either wild-type DJ-1 or L166P usually results in a lower expression level of L166P compared with wild-type DJ-1 because of the instability of L166P (Macedo et al., 2003; Miller et al., 2003; Moore et al., 2003) . Considering this problem, we transfected the cells with increased amounts L166P plasmids to elevate L166P levels as described previously (Junn et al., 2005) . In HEK 293 cells expressing Flag, Flag-DJ-1 or Flag-L166P, endogenous FADD was coimmunoprecipitated when Flag-DJ-1 was immunoprecipitated with anti-Flag antibody. Much less FADD was co-immunoprecipitated with Flag-L166P ( Figure 4B ). We also performed the reverse co-immunoprecipitation assays to validate the interactions between DJ-1 and FADD using anti-green fluorescent protein (GFP) antibodies to immunoprecipitate enhanced GFP (EGFP)-FADD. In H1299 cells co-transfected with EGFP-FADD and hemagglutinin (HA), HA-DJ-1 or HA-L166P, it was observed that HA-DJ-1 was coimmunoprecipitated at significant levels, whereas much less L166P was obtained ( Figure 4C ). Furthermore, when endogenous FADD was immunoprecipitated from HCT116 p53À/À cells using anti-FADD antibodies, endogenous DJ-1 was co-immunoprecipitated ( Figure 4D ). As DJ-1 and L166P were both found to be able to interact with FADD in our GST pull-down assays, but L166P does not interact with FADD to the same extent as DJ-1, we considered the possibility that there might be differences in the distribution of these proteins. We therefore examined the subcellular localization of DJ-1, L166P and FADD using fractionation assays and immunofluorescent staining. We transfected HEK 293 cells with Flag-FADD and myc, myc-DJ-1 or myc-L166P, and examined the resulting protein levels in mitochondrial and cytosolic fractions. In HEK 293 cells transfected with Flag, Flag-DJ-1 or Flag-L166P, it was found that DJ-1 and L166P were present in both the Extracts from HCT116 p53À/À cells were subjected to immunoprecipitation analysis using anti-FADD antibodies or rabbit immunoglobulin G (IgG) as a control. Immunoprecipitates were detected with antibodies to DJ-1 and FADD. (E) The distributions of Flag-DJ-1 and Flag-L166P in cytosolic and mitochondrial fractions were determined using immunoblot analysis. At 36 h after transfection, H1299 cells expressing Flag, Flag-DJ-1 or Flag-L166P were subjected to subcellular fractionation assays. The cellular fractions were then subjected to immunoblot analysis with antiFlag antibody, anti-FADD antibodies, anti-Tom20 antibody (used as a mitochondrial marker) and anti-a-tubulin antibody (used as a cytosolic marker). (F) The subcellular distributions of DJ-1 and L166P were shown using immunocytochemical staining. HEK 293 cells were co-transfected with plasmids expressing myc (a), myc-DJ-1 (b), myc-L166P (c) and EGFP-mito (d-f), along with Flag-FADD (g-i). At 36 h after transfection, the cells were fixed and subjected to immunocytochemical analysis with anti-myc antibody (a-c, red) and anti-Flag antibody (g-i, blue). EGFP-Mito was used as a mitochondrial marker (d-f, green). (G) DJ-1-knockdown HCT116 p53À/ À cells were transfected with Flag-DJ-1(s) or Flag-L166P(s) to restore DJ-1 levels. At 72 h after transfection, the cells were treated with 40 ng/ml TRAIL for 8 h to induce apoptosis. Immunoblot analysis demonstrated the activation of caspase-8 and cleavage of PARP using the indicated antibodies.
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K Fu et al mitochondria and the cytosol. Although more L166P was found in the mitochondrial fraction, endogenous FADD was cytosolic ( Figure 4E ). Consistent with previous studies Shinbo et al., 2006) , immunofluorescent staining showed that DJ-1, similar to FADD, was distributed diffusely throughout the cells ( Figure 4F ). However, L166P was mainly localized to mitochondria, with much less being localized in the cytosol and nucleus ( Figure 4F ). To further assess the effects of DJ-1 and L166P on TRAILmediated cell death, we transfected DJ-1(s) or L166P(s) into DJ-1-knockdown HCT116 p53À/À cells. Overexpression of DJ-1(s), but not L166P(s), decreased the levels of PARP cleavage and blocked the activation of pro-caspase-8 in DJ-1-knockdown HCT116 p53À/À cells treated with TRAIL ( Figure 4G ). These results suggest that DJ-1, but not L166P, interacts with FADD and inhibits TRAIL-induced apoptosis in mammalian cells.
DJ-1 competes with pro-caspase-8 for binding to the DED of FADD
Because FADD interacts with both DJ-1 (Figure 4 ) and pro-caspase-8 (Medema et al., 1997; Ashkenazi and Dixit, 1998), we tested whether DJ-1 could interrupt the binding of pro-caspase-8 to FADD. To identify which domain of FADD interacts with DJ-1, we created FADD mutants containing either the DED (amino acids 1-80) or death domain (amino acids 81-208) and fused them to GST (Figure 5a ). Using in vitro GST pull-down assays, we found that purified Flag-DJ-1 expressed by E. coli directly interacted with the N-terminus of FADD, which contains the DED, but not with the C-terminus of FADD, which contains the death domain ( Figure 5b ). Notably, DJ-1 did not interact with the DED domains of caspase-8 (Supplementary Figure S1) . Because the N-terminal DEDs of procaspase-8 also bind to the N-terminal DED of FADD, we performed competitive binding assays to determine whether DJ-1 influences the interactions between FADD and caspase-8. Fixed amounts of GST-caspase-8 (amino acids 1-183) coupled to glutathione agarose beads were incubated with fixed amounts of Flag-FADD expressed in E. coli along with increasing amounts of His-DJ-1. Immunoblot analysis showed that the binding of the N-terminus of caspase-8 to FADD was significantly decreased with increased amounts of DJ-1 (Figure 5c ). We examined the levels of pro-caspase-8 binding to EGFP-FADD in DJ-1-knockdown cells using co-immunoprecipitation assays.
In DJ-1-knockdown H1299 cells, more endogenous procaspase-8 was co-immunoprecipitated with FADD compared with control-knockdown cells (Figures 5d  and e) . We next tested whether L166P could influence the interactions between FADD and caspase-8. In H1299 cells co-transfected with EGFP-FADD and HA, HA-DJ-1 or HA-L166P, overexpression of HA-DJ-1, but not L166P, decreased the levels of endogenous pro-caspase-8 that were co-immunoprecipitated with EGFP-FADD (Figures 5f and g ). This suggests that L166P does not affect the binding of caspase-8 to FADD. Moreover, the interactions between DJ-1 and DR4 induced by TRAIL treatment suggest that DJ-1 is recruited to DISC (Supplementary Figure S2) . To further explore whether DJ-1 affects DISC function, we performed DJ-1 knockdown experiments in MCF-7 cells and stimulated the cells with TRAIL to induce the recruitment of FADD and DISC formation. Immunoblot analysis showed that the knockdown of DJ-1 resulted in increased interactions between endogenous FADD and pro-caspase-8 on TRAIL treatment (Figure 5h) , and similar results were obtained using HCT116 p53 þ / þ cells (Supplementary Figure S3) . However, the knockdown of DJ-1 had no effect on the interactions between endogenous FADD and DR4 (Figure 5h) . Moreover, DJ-1 knockdown in MCF-7 cells increased the interactions between pro-caspase-8 and DR4 (Supplementary Figure S4) . Furthermore, neither DJ-1 nor L166P interacts with pro-caspase-8 (Supplementary Figure S5) , and DJ-1 did not change the level of pro-caspase-8 (Supplementary Figure S6) . These data suggest that DJ-1, but not L166P, competes with caspase-8 for binding to the DED of FADD in mammalian cells.
Discussion
In this study, we demonstrated that DJ-1 regulates TRAIL-induced apoptosis by blocking the interactions between FADD and pro-caspase-8. TRAIL, a member of the TNF family of cytokines (Wiley et al., 1995) , represents a promising candidate for cancer treatment because of its ability to induce apoptosis selectively in cancer cells (Wang and El-Deiry, 2003; Johnstone et al., 2008) . At the cell surface, binding of TRAIL to DR4 and DR5 leads to the recruitment of an adapter protein FADD and induces DISC formation to promote procaspase-8 activation (Scaffidi et al., 1999) . FADD interacts with the DR(s) through its death domain and with pro-caspase-8 through its DED (Medema et al., 1997; Ashkenazi and Dixit, 1998) . Recruitment of procaspase-8 by FADD on TRAIL treatment results in the auto-processing and activation of pro-caspase-8 (Chang et al., 2003) . On caspase-8 activation, BID, a BH3 domain-containing protein that is a target for active caspase-8, is cleaved to generate an activated form of BID, truncated BID (Li et al., 1998) . truncated BID functions in mitochondria, causing the release of mitochondrial apoptotic factors, such as cytochrome c, into the cytosol (Li et al., 1998) . Moreover, active caspase-8 cleaves and activates the effector protein caspase-3 (Stennicke et al., 1998) to cleave various substrates, including PARP, a-fodrin and lamin A (Nicholson et al., 1995; Oliver et al., 1998) . It has been reported that the oncoprotein MUC1 and PEA-15 can block death receptor-mediated apoptosis by binding to the DED of FADD and inhibiting procaspase-8 recruitment (Condorelli et al., 1999; Agata et al., 2008) . Similar to these proteins, DJ-1 bound directly to the DED of FADD (Figure 5b) , which is required for its interaction with pro-caspase-8, to compete with caspase-8 to bind to FADD (Figure 5c ). These data provide evidence that DJ-1 blocks the interactions between FADD and pro-caspase-8 through a specific interaction with the DED of FADD. Although DJ-1 and L166P both interacted with FADD in GST pull-down assays, much less L166P interacted with FADD in mammalian cells. Moreover, the overexpression of L166P did not influence the interactions between pro-caspase-8 and FADD (Figures 5f and g ). Consistent with our observations, L166P has been reported to localize to the mitochondria and apparent loss of the cytoplasmic functions of DJ-1 (Figures 4E and F ; Bonifati et al., 2003) . In contrast, wild-type DJ-1 is distributed diffusely in the cytoplasm and the nucleus, similarly to the subcellular localization of FADD ( Figures 4E and F) . It is possible that the instability of L166P or its mislocalization to the mitochondria may be DJ-1 regulates TRAIL-induced apoptosis K Fu et al responsible for its weak association with FADD. In our experiments, DJ-1 did not block active caspase-8-induced apoptosis when we used an inducible biochemical system for caspase-8 activation that is independent of the formation of DISC (Figure 2 ). This suggests that DJ-1 does not function downstream of caspase-8 activation or its effector caspases and their substrates. It has been reported that DJ-1 inhibits apoptosis by regulating different transcription factors to modulate gene expression (Clements et al., 2006; Bretaud et al., 2007; Fan et al., 2008a; Vasseur et al., 2009; Foti et al., 2010) . However, we observed that DJ-1 did not affect DR mRNA or protein levels in H1299 cells (Figure 3) . Taken together, our data suggest that DJ-1 affects DISC formation to regulate TRAIL-induced apoptosis.
We previously reported that DJ-1 interacts with p53 to inhibit apoptosis (Fan et al., 2008a, b) . To avoid the influence of p53 on apoptosis, we used p53-null cells, as well as cells with wild-type p53 in our experiments. Similar results were obtained using these different cell lines. Moreover, in HCT116 p53À/À cells, DJ-1 inhibited TRAIL-induced pro-caspase-8 activation and cell death, suggesting that DJ-1 can exert its protective effects on TRAIL-induced cell death independently of p53.
In summary, the results of our study showed that DJ-1 inhibits TRAIL-induced apoptosis by blocking pro-caspase-8 recruitment to FADD ( Figure 6 ). As DJ-1 protein levels are tightly associated with the sensitivity of cells to TRAIL-induced apoptosis (Hod, 2004; Zhang et al., 2008) , our study provides a mechanistic explanation for why cancer cells exhibiting higher expression of DJ-1 are more resistant to TRAIL-induced apoptosis.
Materials and methods
Cell culture and transfection HEK 293, HCT116 p53 þ / þ and HCT116 p53À/À cells were cultured in Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY, USA) containing 10% fetal bovine serum (Hyclone Laboratories, Logan, UT, USA) with 100 mg/ml penicillin and 100 mg/ml streptomycin. H1299 and MCF-7 cells were maintained in RPMI medium 1640 (Gibco) supplemented with 10% fetal bovine serum. The cells were transfected with expression plasmids using the Lipofectamine2000 reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions.
RNA interference
The double-stranded oligonucleotides used in this study were designed against human DJ-1 complementary DNA and siNC synthesized by Shanghai GenePharma (Shanghai, China) as described previously (Fan et al., 2008a) . The transfection was performed using Oligofectamine (Invitrogen) according to the manufacturer's instructions. GST, GST-FADD or mutants of GST-FADD coupled to glutathione-agarose beads were incubated with Flag-DJ-1 expressed in E. coli. After incubation, the bound proteins were eluted using sodium dodecyl sulfate sample buffer and subjected to immunoblot analysis with anti-Flag antibody. GST, GST-FADD and mutants of GST-FADD were visualized by coomassie staining. (c) GST or fixed amounts of containing the DEDs were incubated with Flag-FADD in the absence or presence of increasing amounts of His-DJ-1. After incubation, the bound proteins were eluted using sodium dodecyl sulfate sample buffer and subjected to immunoblot analysis with anti-Flag antibody. His-DJ-1 was detected using anti-DJ-1 antibodies. were shown using coomassie staining. (d) H1299 cells were transfected with siNC or siDJ-1. After 36 h, EGFP-FADD was transfected into the cells. At 72 h after transfection, the cell lysates were subjected to immunoprecipitation analysis using anti-GFP antibodies, and the immunoprecipitates were subjected to immunoblot analysis with the indicated antibodies. Representative blots from one of three independent experiments are shown. Figure 6 A proposed model showing that DJ-1 regulates TRAILinduced apoptosis by its interaction with FADD to inhibit procaspase-8 recruitment. DJ-1 physically interacts with FADD in the cytosol. The interactions between DJ-1 and the death effect domain of FADD block pro-caspase-8 recruitment to FADD, thereby inhibiting DISC formation. In contrast to wild-type DJ-1, the PDlinked mutant L166P does not exert effects on FADD-pro-caspase-8 due to its mislocalization to the mitochondria.
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Plasmids pC4M-Fv2E-caspase-8 and the pC4M-Fv2E-caspase-8 C-A mutant (inactive control plasmid) plasmids were kindly provided by Dr Juha Klefstrom (University of Helsinki, Finland) and Dr Xiaolu Yang (University of Pennsylvania). p3 Â Flag-myc-cmv-24-DJ-1, pEGFP-N1-DJ-1, pET-15b-DJ-1, p3 Â Flag-myc-cmv-24-DJ-1(s) and p3 Â Flag-myc-cmv-24-L166P(s) were described previously (Fan et al., 2008a, b; Ren et al., 2010) . Full-length FADD complementary DNA was amplified by PCR with the primers 5 0 -CGGAATTCCATGG ACCCGTTCCTG-3 0 and 5 0 -CGGGATCCTCAGGACGCTT CGGA-3 0 using pGBKT7-FADD (kindly provided by Dr Mian Wu, University of Science and Technology of China, China) as the template. The complementary DNA was cloned into p3 Â Flag-myc-CMV-24 and pEGFP-C1 at EcoR I/BamH I sites. Full-length and deletion mutants of FADD were generated by subcloning PCR products with the following primers into pGEX-5x-1 at EcoR I/Xho I sites: 5 0 -CGGAATT CATGGACCCGTTCCTG-3 0 and 5 0 -CCCTCGAGTCAGG ACGCTTCGGA-3 0 for full-length FADD; 5 0 -CGGAATTCA TGGACCCGTTCCTG-3 0 and 5 0 -CCCTCGAGTCAGTCG ACGCGCCGCAG-3 0 for FADD-N (amino acids 1-80); and 5 0 -CGGAATTCATGGACTTCGAGGCGGGG-3 0 and 5 0 -CC CTCGAGTCAGGACGCTTCGGA for FADD-C (amino acids 81-208). A deletion mutant of caspase-8 encoding amino acids 1-183 (containing DEDs) was created by subcloning the PCR product amplified from pEGFP-C1-pro-caspase-8 using the primers 5 0 -GCGTCGACCCATGGACTTCAGCAGA-3 0 and 5 0 -TTGCGGCCGCTCATTTGCTGAATTCTTC-3 0 into pGEX-5x-1 at Sal I/Not I sites. Constructs expressing Flagtagged DJ-1 or FADD in E. coli were generated by subcloning the PCR products amplified from p3 Â Flag-myc-cmv-24-DJ-1 or p3 Â Flag-myc-cmv-24-FADD with the primers 5 0 -CGGG ATCCGAACCGTCAGAATTAACCATG-3 0 and 5 0 -CCCTC GAGTCAGGACGCTTCGGA-3 0 or 5 0 -CGGGATCCGAAC CGTCAGAATTAACCATG-3 0 and 5 0 -CGCTCGAGCTGCT GGAGTCTTTAAGAAC-3 0 into pET-21a at BamH I/Xho I sites, respectively.
Immunoblot analysis and antibodies
The cell extracts were lysed in 1 Â RIPA lysis buffer (25 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate) in the presence of a protease inhibitor cocktail (Roche, Indianapolis, IN, USA). The proteins were separated by 12 or 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes (Millipore, Bedford, MA, USA).
The following primary antibodies were used. The monoclonal antibodies included anti-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-caspase-8 (Alexis Biochemicals, Lausen, Switzerland), anti-DJ-1 (Santa Cruz Biotechnology), anti-FADD (Epitomics, Burlingame, CA, USA), anti-Flag (Sigma, St Louis, MO, USA), anti-GST (Santa Cruz Biotechnology), anti-GFP (Santa Cruz Biotechnology), anti-HA (Santa Cruz Biotechnology) anti-myc (Santa Cruz Biotechnology), anti-Tom20 (Santa Cruz Biotechnology) and anti-a-tubulin (Merck Calbiochem, San Diego, CA, USA); and the polyclonal antibodies included anti-caspase-8 (BD Pharmingen, San Diego, CA, USA), anti-DcR1 (Santa Cruz Biotechnology), anti-DcR2 (Protein Tech Group Inc., Chicago, IL, USA), anti-DJ-1 (Chemicon, Temecula, CA, USA), anti-DR4 (Boster, China), anti-DR5 (Boster), anti-FADD (Santa Cruz Biotechnology) and anti-PARP (Cell Signaling Technology, Beverly, MA, USA). Sheep anti-mouse immunoglobulin g-horseradish peroxidase and anti-rabbit immunoglobulin-horseradish peroxidase antibodies were purchased from Amersham Pharmacia Biotech (Arlington Heights, IL, USA). The proteins were visualized using an ECL detection kit (Amersham Pharmacia Biotech).
Immunoprecipitation and induction of DISC
The cells transfected with the indicated plasmids were collected at 48 h after transfection. Crude cell lysates were sonicated in TSPI buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM sodium chloride, 1 mM EDTA and 1% NP-40 supplemented with a complete mini protease inhibitor cocktail (Roche). The cellular debris was removed by centrifugation at 12 000 g for 30 min at 4 1C. The supernatants were incubated with antibodies overnight at 4 1C. After incubation, protein G-Sepharose (Roche) was used for precipitation. Finally, sepharose beads were washed four times with RIPA buffer, and the bound proteins were eluted with sodium dodecyl sulfate sample buffer for immunoblot analysis. MCF-7 cells (1 Â 10 7 cells per condition) were treated with TRAIL for 30 min to induce recruitment of FADD and DISC formation as described previously (Bodmer et al., 2000) . The cell lysates were immunoprecipitated with anti-FADD antibodies, and the immunoprecipitates were subjected to immunoblot analysis.
Reverse transcription-PCR Total RNA was extracted from cells using an RNA extraction kit (Takara, China) and used for reverse transcription with an oligo (dT) 18 primer and TransScript RT/RI Enzyme (TransGen, Beijing, China). The specific primers used for mRNA amplification were as follows: 5 0 -GACCTGACTGAC TACCTC-3 0 and 5 0 -GACAGCGAGGCCAGGATG-3 0 for actin; 5 0 -TCGCTGTCCACTTTCGTCT-3 0 and 5 0 -GGCGTT CCGTCCAGTTTTG-3 0 for DR4; 5 0 -AAGACCCTTGTGCT CGTTGT-3 0 and 5 0 -GCTGCAACTGTGACTCCTAT-3 0 for DR5; 5 0 -AAGTTCCCCAGCAGACAGT-3 0 and 5 0 -TCATC CCAGGACGTACAAT-3 0 for DcR1; and 5 0 -ATGGGACT TTGGGGACAAA-3 0 and 5 0 -CTGACCTTGACCATCCCT CTG-3 0 for DcR2.
Subcellular fractionation assay
Mitochondrial and cytosolic fractions were isolated using the Cell Mitochondria Isolation Kit (Beyotime, Nantong, China) according to the manufacturer's instructions. The total cell lysates and the mitochondrial and cytosolic fractions were subjected to immunoblot analysis. Tom20 served as a mitochondrial marker and a-tubulin as a cytosolic marker.
Reagents
To induce apoptosis through death receptors, the cells were treated with TRAIL (R&D Systems, Minneapolis, MN, USA).
To activate Fv-caspase-8, 100 nM AP20187 (ARIAD Pharmaceuticals, Cambridge, MA, USA) was used to dimerize Fv-caspase-8.
3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-diphenytetrazoliumromide (MTT) assay The 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-diphenytetrazoliumromide cell viability assay was described previously (Ren et al., 2010) .
Apoptosis assays
The cells expressing Fv-caspase-8 or Fv-mut-caspase-8 were treated with 100 nM AP20187 or vehicle for 10 h to dimerize Fv-caspase-8, followed by annexin V/propidium iodide staining and flow cytometric analysis, which was described previously (Fan et al., 2008a) .
